nonlinear regression algorithm graphpad prism version 7.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
nonlinear regression algorithm graphpad prism version 7.0
Nonlinear Regression Algorithm Graphpad Prism Version 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+algorithm+graphpad+prism+version+7%2E0/graphpad+prism+software/pm37379455-193-8-10
Average 90 stars, based on 1 article reviews
Nonlinear Regression Algorithm Graphpad Prism Version 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+algorithm+graphpad+prism+version+7%2E0/graphpad+prism+software/pm37379455-193-8-10
Average 90 stars, based on 1 article reviews
nonlinear regression algorithm graphpad prism version 7.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Synthesis and 177 Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant. Article Snippet: The retro analog of the HER2-targeting A9 peptide was synthesized by coupling amino acids in a reverse fashion and switching the N-terminal in the original sequence of the L-A9 peptide (QDVNTAVAW) to the C-terminal in rL-A9 (WAVATNVDQ).. Modification in the backbone resulted in higher conformational stability of the retro peptide as evident from CD spectra.. Molecular docking analysis revealed a higher HER2 binding affinity of [177Lu]Lu-DOTA-rL-A9 than the original radiopeptide [177Lu]Lu-DOTA-L-A9. Article Title: Synthesis and comparative evaluation of 177 Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes Article Snippet: K d value was calculated by the nonlinear Article Title: Targeting HER2-receptors with 177 Lu-labeled triazole stapled cyclic peptidomimetic. Article Snippet: In this study on-resin Cu(I)-catalyzed click reaction was performed to synthesize triazole-stapled cyclic peptidomimetic, DOTA-c[TZ]A9 targeting HER2 receptor expression in breast cancers.. Spectroscopic (circular dichroism) and docking analysis provided evidence of enhanced helicity and secondary structure stabilization along with improved HER2 affinity in comparison to the corresponding linear peptide, DOTA-[Pra1, Aza7]A9.. 177Lu-labeled cyclic peptide, 177Lu-DOTA-c[TZ]A9 displayed higher in vitro serum stability and in vivo metabolic stability and better HER2 binding affinity {Kd of 16.93 ± 3.02 nM} than the linear counterpart, [177Lu]DOTA[Pra1, Aza7]A9 {Kd of 26.28 ± 2.87 nM}. |